K. Oikawa
发表
Y. Shimada,
N. Ikeda,
T. Ochiya,
2022,
Cell reports.
N. Ikeda,
M. Kuroda,
K. Sudo,
2016,
Molecular therapy : the journal of the American Society of Gene Therapy.
M. Kuroda,
Y. Kanno,
Shin-ichiro Ohno,
2019,
Clinical and Experimental Nephrology.
M. Kuroda,
K. Yoshida,
K. Mukai,
2005,
British Journal of Cancer.
Dioxin suppresses the checkpoint protein, MAD2, by an aryl hydrocarbon receptor-independent pathway.
Y. Fujii‐Kuriyama,
T. Ohbayashi,
M. Kuroda,
2001,
Cancer research.
M. Kuroda,
M. Bouvier,
M. Tanaka,
2008,
The Journal of pathology.
N. Ikeda,
M. Kuroda,
K. Sudo,
2016,
Molecular therapy : the journal of the American Society of Gene Therapy.
T. Ishikawa,
M. Kuroda,
E. Sato,
2019,
Laboratory Investigation.
S. Nakae,
M. Kudo,
M. Kuroda,
2009,
Gene Therapy.
Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin’s lymphoma
T. Nagao,
A. Gotoh,
M. Kuroda,
2021,
Scientific Reports.
K. Oikawa,
M. Kuroda,
K. Sudo,
2021,
Oncogene.